Medical Doctor Program year 2025 Reported 2023–2025 Source: CMS Open Payments, 2026 publication

David Backstein

Adult Reconstructive Orthopaedic Surgery Naples, FL Medical Doctor

NPI 1982473641 CMS profile 11525513

1285 Creekside Blvd E Unit 102, Naples, FL 34109

Open in the dashboard

General payments

$199,345

136 records reported · program years 2023–2025

Research payments

$0

Paid to them · None reported · program years 2023–2025

Ownership & investment interest

$2,208

1 holding reported · through program year 2025

Through program year 2025, David Backstein of Naples, FL is reported in the CMS Open Payments database as having received $199,345 across 136 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $2,208 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $90,394 71
2024 General $108,759 64
2023 General $192 1
2025 Ownership $2,208 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Backstein
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to David Backstein were reported at $90,394. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year David Backstein Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $0 $1,416 $292–$9,336 $163
2020 $0 $647 $141–$6,474 $114
2021 $0 $1,073 $211–$6,497 $132
2022 $0 $1,217 $236–$6,299 $149
2023 $192 $1,082 $246–$6,818 $160
2024 $108,759 $1,575 $323–$8,944 $164
2025 $90,394 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2023–2025
  1. MicroPort Orthopedics Inc $182,926 108 payments
  2. Medical Device Business Services, Inc. $11,039 8 payments
  3. Arthrex, Inc. $4,119 9 payments
  4. DePuy Synthes Sales Inc. $736 4 payments
  5. LinkBio Corp $192 1 payment
  6. Innovation Technologies Inc $136 1 payment
  7. Zimmer Biomet Holdings, Inc. $112 1 payment
  8. Heraeus Medical, LLC. $84 4 payments

Every payment, record by record

What the payments were for General payments · program years 2023–2025
  1. Royalty or License $86,599 9 payments
  2. Consulting Fee $53,251 27 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $49,887 24 payments
  4. Travel and Lodging $5,597 22 payments
  5. Food and Beverage $4,011 54 payments
Products named General payments · program years 2023–2025
  1. MPO Medial Pivot Knee $182,299 107 payments
  2. ATTUNE $830 5 payments
  3. MPO Hip System $627 1 payment
  4. Irrisept $136 1 payment
  5. ROSA $112 1 payment
  6. PALACOS $84 4 payments
  7. Velys $67 2 payments
  8. Arthrex $24 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 31 billing codes

Paid by Medicare

$93,790

Of which drugs: $4,038

Medicare patients

224

Average age 76

Services billed

1,329

133 women, 91 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 71%
Ischemic heart disease 29%
Osteoporosis 25%
Depression 23%
Diabetes 18%
Cancer 18%
Atrial fibrillation 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 37 184 $140

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

136 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record